These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27631226)

  • 1. Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients.
    Asil M; Dertli R
    Medicine (Baltimore); 2016 Sep; 95(37):e4763. PubMed ID: 27631226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Guiducci S; Trzcinska-Butkiewicz B; Michalska-Jakubus M; Matucci-Cerinic M; Brzosko M; Krasowska D; Chyczewski L; Kowal K
    Arthritis Res Ther; 2013; 15(3):R69. PubMed ID: 23800379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.
    Dharmapatni AA; Smith MD; Crotti TN; Holding CA; Vincent C; Weedon HM; Zannettino AC; Zheng TS; Findlay DM; Atkins GJ; Haynes DR
    Arthritis Res Ther; 2011 Mar; 13(2):R51. PubMed ID: 21435232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study.
    Llauradó G; González-Clemente JM; Maymó-Masip E; Subías D; Vendrell J; Chacón MR
    PLoS One; 2012; 7(8):e43919. PubMed ID: 22937125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble TWEAK predicts hemodynamic impairment and functional capacity in patients with pulmonary arterial hypertension.
    Filusch A; Zelniker T; Baumgärtner C; Eschricht S; Frey N; Katus HA; Chorianopoulos E
    Clin Res Cardiol; 2011 Oct; 100(10):879-85. PubMed ID: 21479966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.
    Carrero JJ; Ortiz A; Qureshi AR; Martín-Ventura JL; Bárány P; Heimbürger O; Marrón B; Metry G; Snaedal S; Lindholm B; Egido J; Stenvinkel P; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):110-8. PubMed ID: 18945991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients.
    Ates I; Ozkayar N; Akyel F; Topcuoglu C; Akyel S; Barça AN; Dede F
    BMC Nephrol; 2014 Oct; 15():159. PubMed ID: 25273526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease.
    Valdivielso JM; Coll B; Martín-Ventura JL; Moreno JA; Egido J; Fernández E; Blanco-Colio LM
    J Nephrol; 2013; 26(6):1105-13. PubMed ID: 23475462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B.
    Wu R; Zhang Y; Xiang Y; Tang Y; Cui F; Cao J; Zhou L; You Y; Duan L
    J Transl Med; 2018 Apr; 16(1):83. PubMed ID: 29615081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum angiotensin-converting enzyme level as a marker of fibrosis in patients with chronic hepatitis B.
    Purnak T; Beyazit Y; Oztas E; Yesil Y; Efe C; Torun S; Celik T; Tenlik I; Kurt M; Ozaslan E
    J Renin Angiotensin Aldosterone Syst; 2012 Jun; 13(2):244-9. PubMed ID: 22277254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure.
    Ptaszynska-Kopczynska K; Marcinkiewicz-Siemion M; Lisowska A; Waszkiewicz E; Witkowski M; Jasiewicz M; Miklasz P; Jakim P; Galar B; Musial WJ; Kaminski KA
    Cytokine; 2016 Apr; 80():7-12. PubMed ID: 26916171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
    Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
    Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer.
    Avilés-Jurado FX; Terra X; Gómez D; Flores JC; Raventós A; Maymó-Masip E; León X; Serrano-Gonzalvo V; Vendrell J; Figuerola E; Chacón MR
    Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1733-41. PubMed ID: 24858806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble TWEAK levels in severe traumatic brain injury and its prognostic significance.
    Tang B; Zhong Z; Qiu Z; Wu HP; Hu JY; Ma JP; Wu JP
    Clin Chim Acta; 2019 Aug; 495():227-232. PubMed ID: 31009601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble TWEAK independently predicts atherosclerosis in renal transplant patients.
    Turkmen K; Tonbul HZ; Erdur FM; Toker A; Biyik Z; Ozbiner H; Gaipov A; Gul EE; Kayrak M; Solak Y; Ozbek O; Turk S; Covic A
    BMC Nephrol; 2013 Jul; 14():144. PubMed ID: 23849432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rise of soluble TWEAK levels in severely obese subjects after bariatric surgery may affect adipocyte-cytokine production induced by TNFα.
    Maymó-Masip E; Fernández-Veledo S; Garcia España A; Vázquez-Carballo A; Tinahones FJ; García-Fuentes E; Garrifo-Sanchez L; Rodriguez Mdel M; Vendrell J; Chacón MR
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1323-33. PubMed ID: 23783093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum alkaline phosphatase levels as a simple and useful test in screening for significant fibrosis in treatment-naive patients with hepatitis B e-antigen negative chronic hepatitis B.
    Hu J; Zhang X; Gu J; Yang M; Zhang X; Zhao H; Li L
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):817-823. PubMed ID: 30543572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse Relationship between Plasma Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Carotid Intima-Media Thickness among Patients Undergoing Hemodialysis and Peritoneal Dialysis.
    Shi X; Qiu B; Shen H; Feng S; Fu J
    Cardiorenal Med; 2020; 10(3):137-144. PubMed ID: 32126565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus.
    Wang C; Chen LL; Pan HF; Leng RX; Qin WZ; Ye DQ
    Clin Rheumatol; 2012 Feb; 31(2):335-9. PubMed ID: 21968693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
    Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
    Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.